DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia

Study acronym: DecNef
StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: Phase 1/2 → not applicable Show 6 more changesShow less
    • Sponsor changed: New York State Psychiatric Institute to Columbia University
    • Start date pushed from Sep 1, 2026 to Dec 2026
    • Interventions modified
    • Study sites revised (2)
    • Collaborators: 1 to 2
    • Study title expanded, about 3 words
  2. Study sites: 1 to 2
    • Eligibility criteria expanded, about 16 words
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to learn whether a research neurofeedback training approach done during MRI scans may help reduce hallucinations such as the experience of hearing voices persistent despite treatment.
Trial Details
NCT Number NCT07779226
Lead Sponsor Columbia University
Collaborators: New York State Psychiatric Institute, National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Schizophrenia Disorder, Schizoaffecitve Disorder
Related terms Hallucinations, Schizophrenia
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov